{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:35Z","timestamp":1787010215549,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>piperacillin-tazobactam, a widely used broad-spectrum antibiotic, carries a risk of severe adverse reactions, including rare but life-threatening hemophagocytic lymphohistiocytosis (HLH). Elevated procalcitonin (PCT), typically indicative of bacterial infection, can mask this diagnosis, leading to delayed recognition and potentially fatal outcomes. This case underscores the diagnostic challenge of drug-induced HLH mimicking infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>\n                      a 17-year-old female presented with community-acquired pneumonia (CAP) and severe iron deficiency anemia. Initial piperacillin-tazobactam therapy resolved her fever and respiratory symptoms. However, after 6 afebrile days, she developed recurrent high-grade fever (40.3\u00b0C), pancytopenia (WBC 1.81\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, ANC 0.23\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, Hb 80\u2009g\/L, platelets 74\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L), hepatitis (AST 338 U\/L, ALT 221 U\/L), and rising serum ferritin (609.3\u2009ng\/mL) and PCT (3.057\u2009ng\/mL).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>comprehensive evaluation excluded new infections (bacterial, viral including EBV\/CMV), malignancies, autoimmune disorders, and other HLH triggers. Bone marrow morphology revealed hemophagocytic cells. Based on HLH-2004 criteria, she fulfilled 5 diagnostic criteria: fever, \u22652 lineage cytopenias, hyperferritinemia, hemophagocytosis in bone marrow, and progressive splenomegaly. The temporal association with drug exposure and resolution upon withdrawal confirmed piperacillin-tazobactam-induced HLH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>piperacillin-tazobactam was immediately discontinued upon suspicion of drug reaction. Despite elevated PCT prompting initiation of imipenem-cilastatin, the patient\u2019s fever resolved spontaneously carbapenem before administration, and liver enzymes began improving the next day.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>following piperacillin-tazobactam cessation, fever resolved permanently within hours. Cytopenias, liver dysfunction, elevated ferritin, and PCT normalized progressively without specific HLH-directed immunosuppressive therapy. The patient was discharged symptom-free. Normal complete blood counts were confirmed at outpatient follow-ups over 13 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>piperacillin-tazobactam can induce HLH, a critical diagnosis requiring immediate drug withdrawal. Elevated PCT in this context is a significant diagnostic pitfall, misleadingly suggesting bacterial infection progression. Unexplained fever and cytopenia during piperacillin-tazobactam therapy \u2013 even with elevated PCT \u2013 should prompt urgent evaluation for drug-induced HLH. Discontinuation of the causative agent is paramount for recovery and may obviate the need for unnecessary antimicrobial escalation or immunosuppressive therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045675","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:02:46Z","timestamp":1764169366000},"page":"e45675","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Piperacillin-tazobactam-induced hemophagocytic lymphohistiocytosis in a patient with community-acquired pneumonia: A case report and literature review on diagnostic challenges of elevated procalcitonin"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7590-529X","authenticated-orcid":false,"given":"Xi","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qing","sequence":"additional","affiliation":[{"name":"Department of General medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaFu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0251-5302","authenticated-orcid":false,"given":"Hui","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"213S","DOI":"10.1592\/phco.20.14.213S.35045","article-title":"Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.","volume":"20","author":"Lister","year":"2000","journal-title":"Pharmacotherapy"},{"key":"R2-20260514","first-page":"e42839","article-title":"Severe Cutaneous Adverse Reaction to Piperacillin-Tazobactam: A Case of Stevens-Johnson Syndrome.","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2169\/internalmedicine.2603-18","article-title":"Association of adverse drug events with broad-spectrum antibiotic use in hospitalized patients: a single-center study.","volume":"58","author":"Hagiya","year":"2019","journal-title":"Intern Med"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"20240931","DOI":"10.1515\/med-2024-0931","article-title":"Adverse reactions of piperacillin: a literature review of case reports.","volume":"19","author":"Zhang","year":"2024","journal-title":"Open Med (Wars)"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaip.2015.03.008","article-title":"Dress induced by piperacillin-tazobactam in a child.","volume":"3","author":"Gonz\u00e1lez D\u00edaz","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R6-20260514","first-page":"353","article-title":"Piperacillin-tazobactam-induced drug hypersensitivity syndrome.","volume":"77","author":"Fahim","year":"2006","journal-title":"Cutis"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"493","DOI":"10.18176\/jiaci.0904","article-title":"Drug-induced hypersensitivity syndrome with hemophagocytic lymphohistiocytosis related to piperacillin-tazobactam: a case report.","volume":"33","author":"Shen","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5021\/ad.2016.28.1.98","article-title":"Piperacillin\/Tazobactam-Associated Hypersensitivity Syndrome with Overlapping Features of Acute Generalized Exanthematous Pustulosis and Drug-Related Rash with Eosinophilia and Systemic Symptoms Syndrome.","volume":"28","author":"Kim","year":"2016","journal-title":"Ann Dermatol"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.245.55","article-title":"Onset of hemophagocytic lymphohistiocytosis during piperacillin-tazobactam therapy in three children with acute focal bacterial nephritis.","volume":"245","author":"Miyabayashi","year":"2018","journal-title":"Tohoku J Exp Med"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"e28657","DOI":"10.1002\/pbc.28657","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)-associated hemophagocytic lymphohistiocytosis (HLH), an important and underrecognized HLH mimic: a case report.","volume":"68","author":"Carter Febres","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"951714","DOI":"10.3389\/fmed.2022.951714","article-title":"Drug-induced hypersensitivity syndrome with high procalcitonin levels due to piperacillin\/tazobactam and meropenem: a case report.","volume":"9","author":"Song","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:06:07Z","timestamp":1778756767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":12,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045675","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-03-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}